Andrew M Bellizzi
Overview
Explore the profile of Andrew M Bellizzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
2051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez-Ramirez J, Hoffman M, Keech J, Snow A, Bellizzi A, Rajan A
Head Neck Pathol
. 2025 Jan;
19(1):7.
PMID: 39775186
We describe the novel occurrence of a adenocarcinoma involving the trachea, with distinct solid and glandular components, in a 34-year-old patient. We illustrate its morphological and immunophenotypic features and describe...
2.
Borbon L, Sherman S, Breheny P, Chandrasekharan C, Menda Y, Bushnell D, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1193-1194.
PMID: 39578324
No abstract available.
3.
Borbon L, Sherman S, Breheny P, Chandrasekharan C, Menda Y, Bushnell D, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1136-1148.
PMID: 39505730
Background: Peptide receptor radionuclide therapy (PRRT) is an effective treatment for advanced gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). We investigated a 2-decade experience with PRRT to determine whether PRRT confers a...
4.
Howe J, Menda Y, Chandrasekharan C, Bellizzi A, Quelle D, ODorisio M, et al.
Endocr Pract
. 2024 Sep;
31(1):4-18.
PMID: 39349242
The Iowa Neuroendocrine Tumor (NET) Clinic was founded and developed by two remarkable physicians, Thomas and Sue O'Dorisio. Tom was an Endocrinologist and close friend and colleague of Aaron Vinik....
5.
Yavas A, Ozcan K, Adsay N, Balci S, Tarcan Z, Hechtman J, et al.
Mod Pathol
. 2024 Aug;
37(11):100585.
PMID: 39094734
Inactivating alterations in the SWItch/Sucrose NonFermentable (SWI/SNF) Chromatin Remodeling Complex subunits have been described in multiple tumor types. Recent studies focused on SMARC subunits of this complex to understand their...
6.
Vaughn H, Major H, Kadera E, Keck K, Dunham T, Qian Q, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39062773
Functional copy-number alterations (fCNAs) are DNA copy-number changes with concordant differential gene expression. These are less likely to be bystander genetic lesions and could serve as robust and reproducible tumor...
7.
Tu B, Khalyfa A, Bellizzi A, Tanaka T
ACG Case Rep J
. 2024 May;
11(5):e01348.
PMID: 38725478
This report describes a rare case of hepatocellular carcinoma (HCC) concurrent with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) without traditional risk factors, such as hepatic fibrosis or chronic hepatitis. Initially...
8.
Chauhan A, Chan K, Halfdanarson T, Bellizzi A, Rindi G, OToole D, et al.
CA Cancer J Clin
. 2024 Apr;
74(4):359-367.
PMID: 38685134
The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP-NETs), is meant to be dynamic, requiring periodic updates to optimize AJCC staging...
9.
Goldsmith J, Troxell M, Roy-Chowdhuri S, Colasacco C, Edgerton M, Fitzgibbons P, et al.
Arch Pathol Lab Med
. 2024 Feb;
148(6):e111-e153.
PMID: 38391878
Context.—: In 2014, the College of American Pathologists developed an evidence-based guideline to address analytic validation of immunohistochemical assays. Fourteen recommendations were offered. Per the National Academy of Medicine standards...
10.
Pietan L, Vaughn H, Howe J, Bellizzi A, Smith B, Darbro B, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139230
Determining neuroendocrine tumor (NET) primary sites is pivotal for patient care as pancreatic NETs (pNETs) and small bowel NETs (sbNETs) have distinct treatment approaches. The diagnostic power and prioritization of...